| Product Code: ETC9385006 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Africa Large Molecule Drug Substance CDMO Market Overview |
3.1 South Africa Country Macro Economic Indicators |
3.2 South Africa Large Molecule Drug Substance CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 South Africa Large Molecule Drug Substance CDMO Market - Industry Life Cycle |
3.4 South Africa Large Molecule Drug Substance CDMO Market - Porter's Five Forces |
3.5 South Africa Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.6 South Africa Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.7 South Africa Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 South Africa Large Molecule Drug Substance CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for biologics and biosimilars in the pharmaceutical industry |
4.2.2 Growth in outsourcing of manufacturing activities by pharmaceutical companies |
4.2.3 Government initiatives to promote healthcare infrastructure and innovation in South Africa |
4.3 Market Restraints |
4.3.1 High initial investment and operational costs for setting up large molecule drug substance manufacturing facilities |
4.3.2 Stringent regulatory requirements and compliance standards in the pharmaceutical industry |
4.3.3 Limited availability of skilled workforce and technical expertise in large molecule drug substance manufacturing |
5 South Africa Large Molecule Drug Substance CDMO Market Trends |
6 South Africa Large Molecule Drug Substance CDMO Market, By Types |
6.1 South Africa Large Molecule Drug Substance CDMO Market, By Service |
6.1.1 Overview and Analysis |
6.1.2 South Africa Large Molecule Drug Substance CDMO Market Revenues & Volume, By Service, 2021- 2031F |
6.1.3 South Africa Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Manufacturing, 2021- 2031F |
6.1.4 South Africa Large Molecule Drug Substance CDMO Market Revenues & Volume, By Clinical, 2021- 2031F |
6.1.5 South Africa Large Molecule Drug Substance CDMO Market Revenues & Volume, By Commercial, 2021- 2031F |
6.1.6 South Africa Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Development, 2021- 2031F |
6.1.7 South Africa Large Molecule Drug Substance CDMO Market Revenues & Volume, By Cell Line Development, 2021- 2031F |
6.1.8 South Africa Large Molecule Drug Substance CDMO Market Revenues & Volume, By Process Development, 2021- 2031F |
6.2 South Africa Large Molecule Drug Substance CDMO Market, By Source |
6.2.1 Overview and Analysis |
6.2.2 South Africa Large Molecule Drug Substance CDMO Market Revenues & Volume, By Mammalian, 2021- 2031F |
6.2.3 South Africa Large Molecule Drug Substance CDMO Market Revenues & Volume, By Microbial, 2021- 2031F |
6.2.4 South Africa Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
6.3 South Africa Large Molecule Drug Substance CDMO Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 South Africa Large Molecule Drug Substance CDMO Market Revenues & Volume, By Biotech Companies, 2021- 2031F |
6.3.3 South Africa Large Molecule Drug Substance CDMO Market Revenues & Volume, By CRO, 2021- 2031F |
6.3.4 South Africa Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
7 South Africa Large Molecule Drug Substance CDMO Market Import-Export Trade Statistics |
7.1 South Africa Large Molecule Drug Substance CDMO Market Export to Major Countries |
7.2 South Africa Large Molecule Drug Substance CDMO Market Imports from Major Countries |
8 South Africa Large Molecule Drug Substance CDMO Market Key Performance Indicators |
8.1 Percentage increase in the number of biologics and biosimilars in the South African pharmaceutical market |
8.2 Number of new partnerships and collaborations between pharmaceutical companies and CDMOs in South Africa |
8.3 Investment in research and development for large molecule drug substance manufacturing technologies |
8.4 Percentage increase in the adoption of advanced manufacturing technologies for large molecule drug substances |
8.5 Number of skilled workforce training programs and certifications in large molecule drug substance manufacturing industry |
9 South Africa Large Molecule Drug Substance CDMO Market - Opportunity Assessment |
9.1 South Africa Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Service, 2021 & 2031F |
9.2 South Africa Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Source, 2021 & 2031F |
9.3 South Africa Large Molecule Drug Substance CDMO Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 South Africa Large Molecule Drug Substance CDMO Market - Competitive Landscape |
10.1 South Africa Large Molecule Drug Substance CDMO Market Revenue Share, By Companies, 2024 |
10.2 South Africa Large Molecule Drug Substance CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here